輸入代號或公司名稱後按 Enter
1781

合世

+0.10 (+0.99%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
10.201成交張數本益比1.59股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.32-1.07-0.15-15.8%-4.94%-15.59%
2026Q1-0.19-258.3%-1.61-0.09-9.2%-2.81%-21.46%
2025Q4-0.18-220.0%-1.30-0.09-7.4%-2.67%-17.28%
2025Q3-0.38-231.0%-0.97-0.18-20.0%-5.31%-12.73%
2025Q2-0.86-0.30-0.41-58.8%-10.92%-4.10%
2025Q10.12-60.0%0.330.064.6%1.42%4.17%
2024Q40.150.510.074.5%1.84%6.66%
2024Q30.29-42.0%-0.210.146.1%3.81%-2.63%
2024Q2-0.230.00-0.11-9.5%-3.24%-0.06%
2024Q10.30-0.150.147.1%4.17%-1.95%
2023Q4-0.57-0.70-0.27-23.3%-7.71%-9.39%
2023Q30.50212.5%-0.430.2411.1%6.66%-5.47%
2023Q2-0.38-3900.0%-0.77-0.18-12.5%-5.08%-10.24%
2023Q1-0.25-0.38-0.12-9.3%-3.30%-5.01%
2022Q4-0.30-0.37-0.14-6.2%-3.75%-4.67%
2022Q30.16-0.760.083.2%2.07%-9.14%
2022Q20.01-1.390.000.2%0.09%-16.62%
2022Q1-0.24-152.2%-2.01-0.11-7.8%-3.08%-22.98%
2021Q4-0.69-1.31-0.33-14.3%-8.36%-15.22%
2021Q3-0.47-110.4%-1.00-0.22-12.7%-5.26%-10.68%
2021Q2-0.61-269.4%4.00-0.29-14.7%-6.44%54.18%
2021Q10.464.970.2210.2%4.78%65.60%
2020Q4-0.384.34-0.18-7.8%-3.88%58.28%
2020Q34.534.272.1592.4%58.09%53.23%
2020Q20.36-0.570.178.0%6.47%-9.38%
2020Q1-0.17-1.40-0.08-7.6%-3.08%-22.51%
2019Q4-0.45-1.61-0.21-22.4%-7.65%-24.80%
2019Q3-0.31-1.36-0.15-12.9%-4.91%-19.84%
2019Q2-0.47-1.17-0.22-20.9%-6.93%-16.39%
2019Q1-0.38-0.83-0.18-17.2%-5.33%-11.09%
2018Q4-0.20-0.81-0.09-8.4%-2.63%-10.34%
2018Q3-0.12-1.01-0.06-3.0%-1.63%-12.41%
2018Q2-0.13-1.07-0.06-2.9%-1.64%-12.74%
2018Q1-0.36-1.25-0.17-19.0%-4.37%-14.52%
2017Q4-0.40-1.44-0.19-14.0%-4.65%-15.97%
2017Q3-0.18-1.32-0.08-5.7%-2.03%-14.12%
2017Q2-0.31-1.35-0.15-12.1%-3.51%-14.18%
2017Q1-0.55-1.52-0.26-19.8%-5.92%-15.23%
2016Q4-0.28-1.59-0.13-8.7%-2.82%
2016Q3-0.21-0.10-4.6%-2.09%